{"symbol": "MRUS", "companyName": "Merus N.V.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.merus.nl", "description": "Merus NV is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics.", "CEO": "Ton Logtenberg", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}